Immunogenicity of cultured keratinocyte allografts deficient in major histocompatibility complex antigens

Journal of Trauma - Injury, Infection and Critical Care

Volumn 45, Issue 1, 1998, Pages 25-34

  Hultman, C Scott ^a   Hunt, John P ^a   Yamamoto, Hiromasa ^a   Giannopoulos, Athina ^a   DeSerres, Suzan ^a   Frelinger, Jeffrey A ^a   Meyer, Anthony A ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN;

ALLOGRAFT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BURN; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOGENICITY; KERATINOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SENSITIZATION; SKIN ALLOGRAFT;

EID: 0031841121     PISSN: 00225282     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005373-199807000-00005     Document Type: Article

References (49)

1. Hefton JM, Madden MR. Finkelstein JL, Shires GT. Grafting of burn patients with allografts of cultured epidermal cells. Lancet. 1983;2:428-430.
2. Madden MR, Finkelstein JL, Staiano-Coico L, et al. Grafting of cultured allogeneic epidermis on second- and third-degree burn wounds on 26 patients. J Trauma. 1986; 26:955-962.
3. Malakhov SF, Paramonov BA, Vasiliev AV, Terskikh VV. Preliminary report of the clinical use of cultured allogeneic keratinocytes. Burns. 1994;20:463-466.
4. Burke JF, May JW, Albright N, Quinby WC, Russell PS. Temporary skin transplantation and immunosuppression for extensive burns. N Engl J Med. 1974:290:269-271.
5. Faure M, Mauduit G, Demidem A, Thivolet J. Langerhans cell free epidermis used as permanent skin allografts in humans [abstract]. J Invest Dermatol. 1986;86:474.
6. Phillips TJ. Cultured epidermal allografts: a temporary or permanent solution? Transplantation. 1991;51:937-941.
7. Hultman CS, Cairns BA, Yamamoto H, deSerres S, Frelinger JA, Meyer AA. The effect of burn injury on allograft rejection, alloantigen processing, and cytotoxic T lymphocyte sensitization. J Burn Care Rehabil. 1995; 16:573-580. The Moyer Award.
8. Auchincloss H. Sultan H. Antigen processing and presentation in transplantation. Current Opinion in Immunology. 1996;8:681-687.
9. Berke B. Unlocking the secrets of CTL and NK cells. Immunol Today. 1995;16:343-346.
10. Rosenberg AS, Singer A. Cellular basis of allograft rejection: an in vivo model of immune-mediated tissue destruction. Annu Rev Immunol. 1992;10:333-358.
11. Kobayashi E, Fujiwara M. Mechanism of rejection of MHC class II-disparate murine skin grafts. I. Immunohistochemical analysis of T-cell subsets infiltrating the site of the graft. Transplant Proc. 1992;24:419-422.
12. Shoskes DA, Wood KJ. Indirect presentation of MHC antigens in transplantation. Immunol Today, 1994;15:32-38.
13. Lee RS, Grusby MJ, Glimcher LH, Winn HJ, Auchincloss H. Indirect recognition by helper cells can induce donor-specific cytotoxic T lymphocytes in vivo. J Exp Med. 1994; 179:865-872.
14. + T cells in major histocompatibility complex class II-deficient mice. Science. 1991;253:1417-1420.
15. Cosgrove D, Gray D, Dierich A, et al. Mice lacking MHC class II molecules. Cell. 1991;66:1051-1066.
16. 2-microglobulin in transplantation. Transplantation. 1995;60:215-220.
17. 2-microglobulin-deficient mice. J Exp Med. 1992;175:885-893.
18. Grusby MJ, Auchincloss H, Lee R, et al. Mice lacking major histocompatibility complex class I and class II molecules. Proc Natl Acad Sci USA. 1993;90:3913-3917.
19. Dierich A, Chan SH, Benoist C, Mathis D. Graft rejection by T cells not restricted by conventional major histocompatibility complex molecules. Ear J Immunol. 1993; 23:2725-2728.
20. Hergueux J, Bodmer H, Cardell S, et al. Knock-out mice: a new tool for transplantation immunologists. Transplant Proc. 1993;25:30-32.
21. Majzoub JA, Muglia LJ. Knockout mice. N Engl J Med. 1996;334:904-907.
22. Rheinwald JG, Green H. Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinizing colonies from single cells. Cell. 1975;6:331-344.
23. Bailey DW, Usama B. A rapid method of grafting skin on tails of mice. Transplant Bull. 1960;7:424.
24. Medawar PB. The behavior and fate of skin autografts and skin homografts in rabbits. J Anat. 1944;78:176-196.
25. De Luca M, Albanese E, Bondanza S, et al. Multicentre experience in the treatment of burns with autologous and allogeneic cultured epithelium, fresh or preserved in a frozen state. Burns. 1989;15:303-309.
26. Thivolet J, Faure M, Demidem A, Mauduit G. Long-term survival and immunological tolerance of human epidermal allografts produced in culture. Transplantation. 1986; 42:274-280.
27. Fratianne R, Papay F, Housini I, Lang C, Schafer IW. Keratinocyte allografts accelerate healing of split-thickness donor sites: applications for improved treatment of burns. J Burn Care Rehabil. 1993;14:148-154.
28. Phillips TJ, Gilchrest BA. Cultured epidermal allografts as biological wound dressings. Prog Clin Biol Res. 1991; 365:77-94.
29. Nickoloff BJ, Mitra RS, Riser BL, Dixit VM, Varani J. Modulation of keratinocyte motility: correlation with production of extracellular matrix molecules in response to growth promoting and antiproliferative factors. Am J Pathol. 1988;132:543-551.
30. Rue LW, Cioffi WG, McManus WF, Pruitt BA. Wound closure and outcome in extensively burned patients treated with cultured autologous keratinocytes. J Trauma. 1993; 34:662-668.
31. Tompkins RG, Remensnyder JP, Burke JF, et al. Significant reductions in mortality for children with burn injuries through the use of prompt eschar excision. Ann Surg. 1988; 208:576-585.
32. Herndon DH, Barrow RE, Rutan RL, Rutan TC, Desai MH, Abston S. A comparison of conservative versus early excision: therapies in severely burned patients. Ann Surg. 1989;209:547-553.
33. Munster AM. Cultured skin for massive burns: a prospective, controlled trial. Ann Surg. 1996;224:372-377.
34. Compton CC, Gill JM, Bradford DA, Regauer S, Gallico GG, O'Connor NE. Skin regenerated from cultured epithelial autografts on full-thickness burn wounds from 6 days to 5 years after grafting. Lab Invest. 1989;60:600-612.
35. Cairns BA, deSerres S, Matsui M. Frelinger JA, Meyer AA. Cultured mouse keratinocyte allografts prime for accelerated second set rejection and enhanced cytotoxic lymphocyte response. Transplantation. 1994;58:67-72.
36. van der Merwe AE, Mattheyse FJ, van Helden PD, Rossouw DJ. Allografted keratinocytes used to accelerate the treatment of burn wounds are replaced by recipient cells. Burns. 1990;16:193-197.
37. Breidhal AF, Judson RT, Dumble LJ, Clunie GJA. Variable rejection patterns of cultured keratinocyte allografts in the rabbit. Br J Plant Surg. 1993;46:235-239.
38. Kawai K, Ikarashi Y, Tomiyama K, Matsumoto Y, Fujiwara M. Rejection of cultured keratinocyte allografts in presensitized mice. Transplantation. 1993;56:265-269.
39. Demidem A, Faure M, Dezutter-Dambuyant C, Thivolet J. Loss of allogeneic T-cell activating ability and Langerhans cell markers in human epidermal cell cultures. Clin Immunol Immunopathol. 1986;38:319-326.
40. Morhenn VB, Benike CJ, Cox AJ, Charron DJ, Engleman EG. Cultured human epidermal cells do not synthesize HLA-DR. J Invest Dermatol. 1982;78:32-37.
41. Niederwieser D, Aubock J, Troppmair J, et al. IFN-mediated induction of MHC antigen expression on human keratinocytes and its influence on in vitro alloimmune responses. J Immunol. 1988;140:2556-2564.
42. Basham TY, Nickoloff BJ, Merigan TC, Morhenn VB. Recombinant gamma interferon induces HLA-DR expression on cultured human keratinocytes. J Invest Dermatol. 1984; 83:88-90.
43. Gaspari AA, Katz SI. Induction and functional characterization of class II MHC (Ia) antigens on murine keratinocytes. J Immunol. 1988;140:2956-2963.
44. Hultman CS, Napolitano LM, Cairns BA, et al. The relationship between interferon-γ and keratinocyte alloantigen expression after burn injury. Ann Surg. 1995; 222:384-393.
45. Hultman CS, Cairns BA, deSerres S, Frelinger JA, and Meyer AA. Burn injury impairs second-set rejection and CTL reactivity in mice primed by cultured keratinocyte allografts. Transplantation. 1995;60:584-589.
46. + cells stimulated indirectly, cause rejection of "major histocompatibility complex-deficient" skin grafts. Transplantation. 1997: 63:1123-1133.
47. Wecker H, Grusby MJ, Auchincloss H. Effector cells must recognize antigens expressed in the graft to cause efficient skin graft rejection in SCID mice. Transplantation. 1995; 59:1223-1227.
48. Auchincloss H, Lee R, Shea S, Markowitz JS, Grusby MJ, Glimcher LH. The role of "indirect" recognition in initiating rejection of skin grafts from major histocompatibility complex class II-deficient mice. Proc Natl Acad Sci USA. 1993;90:3373-3377.
49. Charlton B, Auchincloss H, Fathman CG. Mechanisms of transplantation tolerance. Ann Rev Immunol. 1994;12:707-734.